Assessment of dapagliflozin effect on diabetic endothelial dysfunction of brachial artery (ADDENDA-BHS2 trial): rationale, design, and baseline characteristics of a randomized controlled trial-Reference-Cited by-同舟云学术

Assessment of dapagliflozin effect on diabetic endothelial dysfunction of brachial artery (ADDENDA-BHS2 trial): rationale, design, and baseline characteristics of a randomized controlled trial

Published:2019-07-31 Issue:1 Volume:11 Page:
ISSN:1758-5996
Container-title:Diabetology & Metabolic Syndrome
language:en
Short-container-title:Diabetol Metab Syndr

Author:

Cintra Riobaldo M. R., ,Soares Alexandre A. S.,Breder Ikaro,Munhoz Daniel B.,Barreto Joaquim,Kimura-Medorima Sheila T.,Cavalcante Pamela,Zanchetta Renata,Breder Jessica Cunha,Moreira Camila,Virginio Vitor W.,Bonilha Isabella,Lima-Junior Jose Carlos,Coelho-Filho Otavio R.,Wolf Vaneza L. W.,Guerra-Junior Gil,Oliveira Daniela C.,Haeitmann Rodrigo,Fernandes Vicente H. R.,Nadruz Wilson,Chaves Fernando R. P.,Arieta Carlos E. L.,Quinaglia Thiago,Sposito Andrei C.^ORCID

Funder

AstraZeneca

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13098-019-0457-3.pdf

Reference57 articles.

1. Nitenberg A, Cosson E, Pham I. Postprandial endothelial dysfunction: role of glucose, lipids and insulin. Diabetes Metab. 2006;32(Spec No2):2S28–33.

2. Fiorentino TV, Prioletta A, Zuo P, Folli F. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des. 2013;19(32):5695–703.

3. Romero-Corral A, Sert-Kuniyoshi FH, Sierra-Johnson J, Orban M, Gami A, Davison D, et al. Modest visceral fat gain causes endothelial dysfunction in healthy humans. J Am Coll Cardiol. 2010;56(8):662–6.

4. Zhang H, Wang Y, Zhang J, Potter BJ, Sowers JR, Zhang C. Bariatric surgery reduces visceral adipose inflammation and improves endothelial function in type 2 diabetic mice. Arterioscler Thromb Vasc Biol. 2011;31(9):2063–9.

5. Ghiadoni L, Taddei S, Virdis A. Hypertension and endothelial dysfunction: therapeutic approach. Curr Vasc Pharmacol. 2012;10(1):42–60.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetic endothelial microangiopathy and pulmonary dysfunction;Frontiers in Endocrinology;2023-03-21

2. Dapagliflozin improves endothelial cell dysfunction by regulating mitochondrial production via the SIRT1/PGC-1α pathway in obese mice;Biochemical and Biophysical Research Communications;2022-07

3. Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: An active-controlled randomised trial;Diabetes & Metabolism;2022-03

4. Effects of SGLT-2 Inhibitors on Vascular Endothelial Function and Arterial Stiffness in Subjects With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Frontiers in Endocrinology;2022-02-16

5. Effect of glycemic control on markers of subclinical atherosclerosis in patients with type 2 diabetes mellitus: A review;World Journal of Diabetes;2021-11-15